Engineered Bacterium Gene Editing for High-Yield Colanic Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing colanic acid (CA) in E. coli strains face challenges such as low yield, long cultivation cycles, and the production of detrimental by-products like PHB, necessitating improved genetic engineering strategies for efficient and high-yield CA production.
Innovation Solution
A recombinant engineered strain is developed by knocking out specific genes related to lipopolysaccharide synthesis and Lon/HNS regulatory proteins, overexpressing transcription activators RcsA and RcsB, and optimizing promoters and ribosome binding sites (RBS) to enhance the expression of genes involved in CA precursor synthesis pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If genes related to lipopolysaccharide synthesis and regulatory proteins are knocked out, then CA yield is improved, but strain stability and growth may be affected
Solution Approach 1:
The patent divides the genetic modification into multiple targeted knockout events (waaL, waaU, waaZ, waaY, waaR, waaO, waaB, waaP, waaG, waaQ, lon, hns genes) rather than random mutagenesis, allowing precise control over which functions are eliminated while preserving others. This segmented approach enables systematic optimization of CA production without compromising essential cellular functions.
Solution Approach 2:
The patent systematically modifies multiple genetic parameters simultaneously - knocking out 13 specific genes while overexpressing others (wcaJ, wcaD, wcaA, wcaB, wcaC, wcaE, wcaF, wcaG, wcaH, wcaI, wcaK, wcaL, wcaM, wcaN, wcaO, wcaP, wcaQ, wcaR, wcaS, wcaT, wcaU, wcaV, wcaW, wcaX, wcaY, wcaZ genes). This multi-parameter genetic optimization achieves high CA yield while maintaining strain viability through coordinated modification of synthesis pathways, regulation, and precursor supply.
2Productivity
If multiple genes are knocked out and overexpressed to improve CA production, then productivity is improved, but device complexity and process difficulty increase
Solution Approach 1:
The complex genetic engineering process is segmented into distinct functional modules: (1) lipopolysaccharide synthesis gene knockouts (waaL, waaU, waaZ, waaY, waaR, waaO, waaB, waaP, waaG, waaQ), (2) regulatory protein knockouts (lon, hns), and (3) colanic acid synthesis gene overexpression (wcaJ, wcaD, wcaA, wcaB, wcaC, wcaE, wcaF, wcaG, wcaH, wcaI, wcaK, wcaL, wcaM, wcaN, wcaO, wcaP, wcaQ, wcaR, wcaS, wcaT, wcaU, wcaV, wcaW, wcaX, wcaY, wcaZ). This modular segmentation makes the complex process manageable and reproducible.
Solution Approach 2:
The patent systematically controls multiple genetic parameters including gene knockout status, gene overexpression levels, promoter strength, and ribosome binding site optimization. By defining specific parameter ranges and combinations for each genetic element, the patent transforms a complex engineering challenge into a controllable process with defined optimization criteria.
3Quantity of substance
If traditional E. coli strains are used for CA synthesis, then ease of manufacture is maintained, but yield and production time are insufficient
Solution Approach 1:
The patent performs preliminary genetic modifications during strain construction, including knockout of 13 genes and overexpression of 24 genes, so that the engineered strain is pre-optimized for high-yield CA production. This preliminary genetic programming eliminates the need for lengthy fermentation optimization periods, reducing overall cultivation cycle time while maintaining high productivity.
Solution Approach 2:
The patent fundamentally changes the biological parameters of E. coli by systematically modifying gene expression profiles - knocking out 13 genes to eliminate competing pathways and overexpressing 24 genes to enhance CA synthesis. These parameter changes transform the strain from a standard laboratory organism into a highly efficient production platform that achieves both high yield and reduced cultivation time.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The present disclosure provides a recombinant engineered strain for efficiently producing colanic acid (CA) and uses thereof. By editing key genes for CA synthesis, that is, rcsA and rcsB, galU, galE, ugD, manB, manC, gmd and fcl genes, acetic acid pathway genes, cofactor regeneration related genes and CA synthesis cluster relatd genes, and by means of overexpression in two modes, i.e., plasmid and genomic integration, the recombinant engineered strain that produces CA with a high yield is obtained. The provided recombinant engineered strain provides a basis for large-scale production..